Swaroopa is a Managing Director and Head of Corporate Access at TD Cowen. Swaroopa has spent the past 10+ years focusing on both the health care and industrial sectors. Prior to joining Cowen, she worked at Barclays Capital for over five years, in Corporate Access and Equity Research, where her primary responsibilities were also in health care and industrials. Prior to Barclays, Swaroopa was at Lehman Brothers as an Associate in Equity Research on the Global Aerospace and Defense team. She holds an MBA from NYU, an MSc from the London School of Economics and a BA from Brandeis University.

Keri P. Mattox was appointed Senior Vice President, Chief Communications and Administration Officer in May 2022, responsible for strategically integrating, aligning and driving investor relations, communications and philanthropy functions and activities, as well as environmental, social and governance (ESG) initiatives. She joined Zimmer Biomet in January 2020 as Senior Vice President, Investor Relations and Chief Communications Officer.

Prior to joining Zimmer Biomet, Ms. Mattox served as Global Lead, Integrated Corporate Communications at W2O Group (now Real Chemistry), an international healthcare-focused marketing and communications firm. There she was responsible for strategically shaping and expanding the firm’s global corporate communications, investor relations, crisis communications, M&A, board engagement and corporate social responsibility/foundation capabilities and offering.

Prior to W2O, Ms. Mattox was Vice President, Corporate & Investor Relations at AmerisourceBergen, a healthcare company ranked #10 on the Fortune 500. She also held executive leadership team level positions at Endo International and Auxilium Pharmaceuticals and spent more than 10 years at communications agencies in leadership positions. Earlier in her career, Ms. Mattox was a reporter with Hearst Newspapers. She holds a B.A. from Boston University and an M.A. in Journalism from the University of Maryland.

With nearly 20 years of Advisory experience, Foli leads Nasdaq’s Global Perception, ESG Sentiment, and Investor Engagement practices. She oversees a globally dispersed team engaging directly with the financial community on behalf of IR professionals, senior level executives, and Boards. Foli and her team provide candid market perspectives and contextual insights to assist corporates with effectively navigating the investment landscape. Further, her team advises IR and senior management teams on buy-side engagement, targeting, and roadshow planning leveraging proprietary data and analytics. The team has partnered with corporates through significant events, including changes in capital deployment, restructurings, M&A, executive turnover, shareholder activism, as well as shifts in the macro, regulatory, and political environment. The team’s research and analyses have aided corporates with gaining a firmer grasp of market expectations, enhancing the Company narrative, engaging more effectively with key stakeholders, and making well-informed strategic decisions. The team’s research has been featured in publications by IR Magazine, IR Society (UK), NIRI, and CNBC.

Previously, at Thomson Reuters, Foli served in a senior strategic role focused on enhancing the IR Advisory customer experience through process reengineering, employee recruitment and training, knowledge share, and cross-regional collaboration. Prior to that, Foli oversaw a team of capital markets analysts providing institutional ownership intelligence and industry insights to companies within the healthcare universe.

Foli currently serves as Co-Chair of Professional Development for Nasdaq’s GLOBE employee network. Foli is a firm believer in the power of mentorship, and has served in this capacity for high school students, college students, and early career and tenured professionals in partnership with a number of organizations. She also sits on the governance and environment committees of Charlotte-based non-profit organizations Young Black Leadership Alliance (YBLA) and Women’s Impact Fund (WIF), respectively.

Foli holds a bachelor’s degree in Economics from Boston University with a minor in Business Administration. After living in New York City for over a decade, Foli relocated to North Carolina with her husband and two children.

Royce is currently the CFO at ZenBusiness. Prior to their current role, Katie served as the SVP, Americas CFO at Cognizant. Over her 8 year tenure at Cognizant she also held the position of VP, Head of Investor Relations and was a Director of the Cognizant Foundation. Katie’s experience also includes working in various investor relations and treasury roles including as an Investor Relations Manager at Selective Insurance. Katie began her career on the buyside as a Research Analyst at Clay Finlay, Inc.

Katie Royce has a BSBA from the University of Richmond – Robins School of Business in Marketing and International Business. Katie also is a CFA Charterholder and earned an Investor Relations certification from New York University. She is currently the Chair of the Board of NIRI.

Tierney Saccavino-Payne is currently IRO at Acorda and also president of TSP Communications. Until 2021, she was the Executive Vice President of Investor Relations and Corporate Affairs at Acorda Therapeutics, a biotechnology company developing therapies for people living with neurological diseases. Ms. Saccavino-Payne served as a member of Acorda’s executive management team and was responsible for the Company’s investor relations, corporate communications, media relations, thought leadership, philanthropic giving and consumer / advocacy outreach. She held various roles of increasing seniority at Acorda since 1998.

Before joining Acorda Ms. Saccavino-Payne had over 10 years’ experience in public relations, marketing, and corporate communications. She was the Manager of Corporate Relations at Adventis, a Boston-based management consulting firm. In that capacity, she was responsible for public relations, corporate promotions, and executive education programs. Previously, she worked in a variety of positions at Fidelity Investments.

Ms. Young has over 20 years of experience in biopharmaceutical industry. Currently, Ms. Young is the chief financial officer at Graphite Bio. In this role, Ms. Young oversees the company’s finance, investor relations and corporate communications functions, and plays a key role in overall corporate strategy. She also serves on the board of directors for PTC Therapeutics.

Previously Ms. Young served as senior biotech analyst and head of research at Cantor Fitzgerald, managing the equity research department covering large cap and small-mid-cap biotechnology companies. Prior to joining Cantor Fitzgerald in 2018, Ms. Young held senior biotech analyst positions at Credit Suisse and Deutsche Bank. Earlier in her career, she was a research policy analyst and president at Marwood Group, providing healthcare-focused advisory services to institutional investors. She began her career at J.P. Morgan in the investment banking and asset management divisions.

Ms. Young earned a B.A. in Economics and Spanish from Duke University. She currently serves on the board of directors for BUILD NYC.

Lauren McDonald is a conference producer at IR Magazine and Corporate Secretary. She brings a wealth of experience from her past roles in campaign organising for The Labour Party in Leeds and Tower Hamlets.

Lauren holds a Masters degree in the History of Race & Resistance and a Bachelors degree in American History & Politics, both from prestigious universities. She uses her expertise and knowledge to inform her current work and ensure high quality outcomes.

In her free time, Lauren is actively involved in a number of charitable causes. She has volunteered with the Girl Guides, the Los Angeles LGBT Center, and regularly donates her time to political campaigns in and around London.

In her role as conference producer at IR Magazine and Corporate Secretary, Lauren is passionate about providing the best experience to all stakeholders and ensuring all events she produces are of the highest quality.